Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Controlled Clinical Outcomes of the Vanguard XP Bicruciate Knee System

NCT02175576 is registered in ClinicalTrials.gov with Zimmer Biomet as lead sponsor.

NCT NCT02175576
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02175576 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Controlled Clinical Outcomes of the Vanguard XP Bicruciate Knee System
Lead sponsor
Zimmer Biomet
Phase
Not applicable
Overall status
Terminated
Start date
October 31, 2014
Completion date
December 31, 2020
Enrollment
50 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

complications, arthroplasty, lower limb deformity, osteoarthritis, post-traumatic deformity, rheumatoid arthritis, traumatic arthritis